Allergan, Medytox Close Licensing Agreement
January 07, 2014 at 09:07 AM EST
Allergan (NYSE: AGN ) and Medytox today announced that they have closed the license agreement which was previously announced on September 25, 2013. Under the terms of the agreement, Allergan will pay